📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

In-Vitro and In-Silico Evaluations of Heterocyclic-Containing Diarylpentanoids as Bcl-2 Inhibitors Against LoVo Colorectal Cancer Cells. (2020)

First Author: Leong SW

Attributed to: Translational development of oncolytic Newcastle Disease Virus for treatment of colorectal cancer funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.3390/molecules25173877

PubMed Identifier: 32858795

Publication URI: http://europepmc.org/abstract/MED/32858795

Type: Journal Article/Review

Volume: 25

Parent Publication: Molecules (Basel, Switzerland)

Issue: 17

ISSN: 1420-3049